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Abstract
Despite positive animal studies, clinical angiogenesis trials have been disappointing, possibly due
to risk factors present in humans but usually unexplored in animals. We recently demonstrated
aging causes impaired collateral remodeling and collateral dropout; here, we investigate potential
mechanisms responsible for these findings. Four-, 10-, and 18-month-C57BL/6J mice were
subjected to femoral artery ligation; flow was measured using laser Doppler perfusion imaging.
Endothelial nitric oxide synthase (eNOS) and phosphorylated eNOS were measured in calf
muscle. Apoptosis was assessed in endothelial (EC) and smooth muscle (SMC) cells isolated from
young and old mice. Angiogenesis was measured using a Matrigel plug assay. Lethally irradiated
young and old mice received bone marrow cells (BMC) from either young or old donors and were
subjected to femoral artery ligation (FAL). BMC mobilization and homing were assessed. Flow
recovery was impaired and less eNOS and phosphorylated eNOS was present in older vs. young
mice (p<0.001 and p=0.015, respectively). ECs and SMCs from older mice were more sensitive to
an apoptotic stimulus, but were rescued by NO-enhancing drugs. In older mice, angiogenesis
(Matrigel plug assay) was impaired, as was mobilization and homing of BM progenitor cells
following FAL. Although both mobilization and homing improved when older mice received
BMC transplantation from young donors, flow recovery failed to improve. Aging impairs BMC
mobilization and homing, collateral responsiveness to angiogenic stimuli, and increases EC and
SMC susceptibility to apoptosis via dysfunctional eNOS signaling. The latter could contribute to
impaired remodeling and collateral dropout. These finding identify potential obstacles to
therapeutic interventions in elderly patients.
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Background
The natural capacity of collaterals to compensate for the reduced flow occurring after
obstruction of a major artery rarely restores maximal flow capacity. The resulting clinical
problems are enormous, as in the USA alone 300,000 to 900,000 patients have persistent
angina despite medical management [1, 2]. Similar issues pertain to patients with peripheral
vascular disease [3].
Despite animal studies demonstrating that multiple interventions enhance collateral flow
recovery following acute arterial ligation, the results of clinical angiogenesis trials have been
disappointing [4, 5]. A key contributor to these disparities may be the impact of risk factors
present in patients but often not in experimental animals [4]. One such risk factor is age.
Thus, after hindlimb ischemia blood flow recovery is lower and ischemic injury is greater in
aged vs. young mice [6]. We have recently definitively documented by direct measurement
of collaterals that two of the mechanisms contributing to these findings are aging-related
collateral rarefaction (decreased collateral number) and impaired collateral remodeling, both
related at least in part to a dysfunctional endothelial nitric oxide synthase (eNOS)/nitric
oxide (NO) signaling pathway (Faber and Epstein, unpublished data).
Collateral remodeling and maintenance of native (i.e., pre-existing) collaterals undoubtedly
are affected by multiple mechanisms that may be compromised by aging. For example,
increased shear stress induced by arterial obstruction is a critically important factor in
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remodeling, followed by homing of progenitor cells to the expanding collaterals which,
through the secretion of cytokines, further enhance the remodeling process. To gain
additional insights into how aging contributes to collateral dysfunction, we therefore
examined the impact of aging on bone marrow (BM) progenitor cell mobilization and their
homing to regions of developing collaterals, and the actual responsiveness of preexisting
collaterals of old mice to the potential therapeutic benefit of administering BM cells derived
from young mice. In addition, aging leads to increased oxidative stress [7–9], a stimulus that
may predispose endothelial cell (ECs) and smooth muscle cell (SMCs) to undergo apoptosis.
Because eNOS/NO signaling exerts anti-apoptotic effects [10], we examined the possibility
that aging-induced eNOS/NO dysfunction predisposes ECs and SMCs to undergo apoptosis,




Animal procedures were approved by the Institutional Animal Care and Use Committee
(MedStar Research Institute). Thirty-eight 4-month-old, five 10-month-old, and thirty-six
18-month-old female C57Bl/6 mice, sedated with ketamine and xylazine, underwent surgery
to remove the right femoral artery [11] B6.129S7-Gt(ROSA)26Sor/J mice (4 and 18 months)
were used as donors in BM transplantation studies. Animals were maintained on a normal
chow diet.
Monitoring Blood Flow Recovery
Laser Doppler perfusion imaging (LDPI; Moor Instruments) was utilized to record serial
blood flow measurements. Imaging was performed after limb hair was removed and mice
had been placed on a heating blanket at 37°C. Perfusion is expressed as a ratio of the
ischemic to normal limb [12]. The laser Doppler instrument used had a penetration of 1 mm.
Since the region of interest that was measured was the foot, the penetration depth should not
be a confounding factor, as the foot thickness is not much greater than 1 mm.
Tissue Collection
At killing, mice were anesthetized using ketamine and xylazine; peripheral blood was
collected and stored in RNALater (Ambion). Gastrocnemius muscle was harvested and snap
frozen in liquid nitrogen. In a subset of mice, the gastrocnemius muscle was harvested and
fixed in OCT for histological assessment. BM was collected from the femur and tibia,
filtered, and pelleted by centrifugation (400×g), and frozen in Trizol (Invitrogen).
RNA Isolation and Gene Expression Analysis
Total RNA was isolated from tissue using Trizol reagent (Life Technologies) and from the
peripheral blood using the RiboPure Kit (Ambion). Samples were reverse transcribed using
the High Capacity cDNA Archive kit (Applied Biosystems, Inc.), according to
manufacturers' instructions. Real-time quantitative PCR was performed on an Applied
Biosystems 7500 Fast Real-Time PCR system, using commercially available primer/probe
sets (Applied Biosystems, Inc.).
Isolation of Aortic Endothelial Cells
Twelve-week-old and 24-month-old mice were killed, and the aortas were removed. The
vessel was cleaned of periadventitial fat and connective tissue, cut into rings, and incubated
in 0.25% Trypsin for 30 min. Rings were transferred to a conical tube and pipetted up and
down in 5% fetal bovine serum (FBS) in Dulbecco's modified Eagle's medium (DMEM).
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Cells were collected by centrifugation at 250×g for 10 min, resuspended by EGM-2
(LONZA, cc-3156), and incubated in 100 mm dishes at 37°C for 24 h.
Isolation of Aortic Smooth Muscle Cells
Thoracic aortas were flushed and excised, and the adventitia and surrounding connective
tissue were removed. Vessels were opened by a longitudinal cut, and the intima and a thin
portion of the subjacent media were removed. The aortas were trimmed and cut into four
pieces, and each piece was placed into a separate well of a 12-well plate containing DMEM
(high glucose) with 20% FBS and antibiotics. The vascular smooth muscle cells migrated
from the tissue and were subcultured in DMEM containing 20% FBS and 5% CO2, as
previously described. [13] SMC phenotype was verified by measuring expression of α-actin
mRNA by RT-PCR. Cells were used prior to passage P12 for all in vitro assays.
Western Blotting Analysis
Gastrocnemius muscle was harvested and snap frozen in liquid nitrogen, or aortic
endothelial cells were used. Total protein lysate (80 μg) was separated on 4∼20% SDS-
polyacrylamide gels and transferred to nitrocellulous membranes. The following primary
antibodies were used: α-eNOS (1:700, BD) and α-phospho-eNOS (Ser 1177; 1:500, Cell
Signaling Technology). Westerns were developed using chemiluminescent reagents
(Supersignal, Pierce), and bands were quantified with densitometry.
Apoptosis Assay
Caspase-3 Assay for TNF-α-Induced EC Apoptosis EC apoptosis was detected using a
caspase-3 activity colorimetric kit (R&D, BF3100). Aortic ECs isolated from young and old
mice (passage 5) were seeded at 1×106 cells/dish in 100 mm culture dishes in triplicate.
Cells were grown for 1 day in EGM-2 medium and then were starved for 6 hours. Cells were
incubated with 30 ng/ml tumor necrosis factor (TNF)-α for 18 h to induce apoptosis. For
rescue experiments, sodium nitroprusside (10 μM) was added with the TNF-α. Cells were
collected in a conical tube by centrifugation at 250×g for 10 min, lysed on ice for 10 min,
and centrifuged at 10,000×g for 1 min. Total protein concentration was measured using a
BCA assay kit (Pierce 23225). Equal amounts (100 μg in 50 μl) of total protein were used
for each reaction, 5 μl DEVD-pNA substrate was added. The optical density was measured
at 405 nm wavelength, according to the manufacturer's instructions.
DAPI Assay for H2O2-Induced SMC Apoptosis SMC isolated from young and old mice
(passage 5) were cultured in 24-well plates at 50,000/well. After 24 h, 50 μm H2O2 was
added and the cells were incubated overnight. Cells were washed three times with
phosphate-buffered saline (PBS) and 4% PFA was added for 5 min, followed by 2 μg/ml of
DAPI. Cells were observed in microscope, and those with an intact nucleus were counted as
live cells.
Matrigel Plug Assay
Angiogenesis was assessed through a Matrigel plug assay. Young (3 months; n=5 per group)
and old (24 months; n=5 per group) female C57 Bl/6 mice were subcutaneously injected
with low growth factor containing Matrigel infused with either bFGF (1 μg/ml or 5 μg/ml),
or PBS (control). After 5 days, the plugs were harvested, paraffin embedded, and stained
using H&E. Angiogenesis was quantified by measuring cell invasion and red blood cell-
containing vessels per section. CD31 staining was used to verify endothelial cell phenotype.
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BM cells were harvested; 5×105 cells were incubated with antiCD26-FITC antibody (e-
Bioscience, 10 μg/ml) at 4°C for 40 min. The CD26-positive cells were sorted on a
FACSAria (Becton Dickinson Immunocytometry Systems, San Jose, CA).
BM Transplantation
BM cells were flushed from femurs and tibias of donor B6.129S7-Gt(ROSA)26Sor/J mice.
Following lethal irradiation with 9.5 Gy, 1×107 BM cells were transplanted into recipient
mice through retro-orbital injection. Recipient mice were maintained in sterile cages for 6
weeks. Chimeric mice were confirmed by detecting Lac Z protein (β-galactosidase staining
of peripheral blood).
Statistical Analysis
Statistical analysis was performed using SAS version 9.1 (SAS Institute, Cary, NC).
Continuous variables were expressed as mean±SD. Blood recovery data were compared
among different age groups by analysis of variance with repeated measure. A t test was used
for Western blotting quantification and caspase-3 assay. A p value of <0.05 was considered
statistically significant.
Results
Collateral Flow Recovery Collateral flow recovery was inversely related to age of the mice
(Fig. 1). Perfusion was impaired in 10- and 18-month-old mice compared with 4-month-old
animals (p<0.001).
Western Blotting Analysis Multiple studies have demonstrated the important role of
upregulation of eNOS and its activity in the remodeling that occurs following occlusion of
the major conduit artery they accompany [14]. However, aging has been shown to decrease
eNOS expression [15, 16] and reduce shear stress-induced release of NO in rats [17]. In our
model, we found that aging decreased eNOS protein in calf muscle at baseline in old vs.
young mice (Fig. 2a, b). It also decreased eNOS phosphorylation (ser-1177). Phosphorylated
eNOS/total eNOS ratio was significantly lower in older mice (p=0.015).
Apoptosis We recently demonstrated that aging leads to collateral vessel rarefaction in
multiple vascular beds (Faber, unpublished data). Since eNOS levels are decreased in the
hindlimb of older mice, we hypothesized that lower levels of eNOS increase the sensitivity
of the cells lining the collaterals to undergo apoptosis, perhaps leading to collateral
rarefaction. Our study results were compatible with such a hypothesis. ECs isolated from old
mice were more sensitive to TNF-α-induced apoptosis (Fig. 3a). Preincubation of the ECs
with the NO donor sodium nitroprusside (SNP) afforded protection from apoptosis (Fig. 3b)
such that caspase activity in the old cells was no different than in the young cells. Rescue of
the ECs by a NO donor suggests deficient NO contributes to the increased sensitivity to
apoptosis.
SMCs derived from old mice were also more sensitive to another apoptotic stimulus H2O2
(p<0.05; Fig. 3c). When the cells were exposed to the phosphodiesterase-5 (PDE-5)
inhibitor, tadalafil, the apoptotic response was attenuated (p<0.05; Fig. 3d). PDE-5 induces
the breakdown of cyclic GMP, an important downstream product of NO signaling,
promoting vasodilatation and arteriogenesis while preventing apoptosis and decreasing
oxidative stress. Thus, the addition of a PDE-5 inhibitor would be expected to prevent
apoptosis, as it leads to an increase in cyclic GMP.
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PDE-5 Expression Interestingly, SMCs from old mice have higher PDE-5 expression
(p=0.005; Fig. 3e), suggesting that cyclic GMP is reduced in these cells, possibly
contributing to an increased sensitivity to apoptosis, increased oxidative stress, and
decreased collateral remodeling.
Matrigel Studies To further assess aging-related impairments in vascular cell function, we
performed a Matrigel assay to quantify endothelial cell responsiveness to an angiogenic
stimuli in vivo. Cellular infiltration to bFGF-impregnated Matrigel plugs was significantly
less in older mice (p=0.02) (Fig. 4a, b) as was the number of red blood cell-containing
vessels (p=0.03) (Fig. 4a, c) and vessels lined by CD31-positive cells (Fig. 4a).
Mobilization of BM-Derived Cells CD26 (dipeptidylpeptidase IV (DPPIV)) is critically
involved in release of BM cells from their stromal BM niche. CD26 is expressed on many
hematopoietic cells, including stem and progenitor cells [18]. One of its substrates is SDF-1
(which is present on mesenchymal stromal cells), and when this is cleaved by CD26 the
chemoattractant properties of SDF-1 for CXCR4 are abolished, thereby releasing the
CXCR4-expressing hematopoietic and progenitor cells from their niche into the circulation.
Christopherson et al. demonstrated that CD26 is critical for G-CSF mobilization of
progenitor cells in mice [19]. When mice were treated with CD26 inhibitors during G-CSF-
induced mobilization, treatment significantly reduces the number of progenitor cells in the
periphery compared with G-CSF mobilization alone [19]. We, therefore, hypothesized that
older mice would have reduced levels of CD26 present in their bone marrow, which would
lead to an impairment in mobilization of bone marrow-derived cells. We found that CD26-
positive cell number in BM was greater in young mice (p<0.05, Fig. 5), that CD26 mRNA
was consistently higher in BM from young mice at baseline and following ischemia, and that
more white blood cells were present in the peripheral blood of young animals 2 h post-
ischemia (p<0.05, data not shown).
Bone Marrow Transplantation We tested whether we could salvage the impaired blood flow
recovery in old mice by reconstituting them with BM from young animals. Mice
reconstituted with BM from young donors had significantly more CD26-positive cells in the
bone marrow (Fig. 6a) and more BM-derived cells (as identified by LacZ staining) in the
ischemic tissue compared with mice reconstituted with BM from old donors (p<0.05, Fig.
6b). These findings indicate that transplanting the marrow from young donors into older
mice did indeed lead to higher levels of CD26 mRNA and to higher numbers of CD26-
positive cells in recipient BM, presumably contributing to the more robust mobilization and
better homing of BM cells to the ischemic tissue even in old recipients. Interestingly,
however, recipient age, rather than BM age, determined flow recovery outcome. Older mice
had poor blood flow recovery regardless of age of the BM donor while young mice had
superior blood flow recovery independent of the BM donor age (Fig. 6c). In other words, the
age of the donor does not matter (p= 0.340)—rather, it is the age of the recipient alone that
determines blood flow recovery following induction of hindlimb ischemia (p<0.001).
Discussion
Collaterals constitute a major compensatory means by which the body enhances flow to
ischemic tissue supplied by blocked arteries, a mechanism seriously compromised by aging
and other risk factors [6, 20, 21]. We have, therefore, initiated a series of studies
investigating the mechanisms by which aging leads to dysfunction of the collateral
circulation.
The present investigation builds on our recent findings— namely, that aging compromises
remodeling of collaterals following acute arterial obstruction (a critical mechanism by which
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collateral function improves following arterial occlusion [22, 23]) and leads to actual
collateral rarefaction (Faber et al., unpublished data). Because aging undoubtedly impairs
multiple pathways that could contribute to defective collateral remodeling and collateral
dropout, including impaired eNOS/NO signaling, in this investigation, we therefore
examined the impact of aging on several potential mechanisms that could impair collateral
function. Thus, we examined the effect of aging on BM progenitor cell mobilization and the
homing of these progenitor cells to regions of developing collaterals (it is believed that these
progenitor cells, through the secretion of cytokines, contribute to enhanced collateral
function). We also examined the actual responsiveness of pre-existing collaterals of old mice
to a collaterogenic stimulus—i.e., to the potential therapeutic benefit of administering BM
cells derived from young mice. In addition, because eNOS/NO signaling exerts anti-
apoptotic effects, we determined whether aging-induced eNOS/NO dysfunction predisposes
endothelial and smooth muscle cells to undergo apoptosis, a mechanism that could
contribute both to impaired collateral remodeling and to collateral dropout. Finally, we
identified a novel mechanism by which aging could further contribute to compromise of the
eNOS/NO system—an increase in the expression of phosphodiesterase-5, an enzyme that
degrades a key downstream product of eNOS/NO signaling cGMP.
Aging-Induced eNOS Dysfunction
To confirm that aging leads to deficient eNOS/NO activity/bioavailability [17, 24-27] in the
model used in this investigation, we first examined the effects of aging on eNOS protein
levels and whether aging compromises eNOS activation and thereby its downstream
signaling. The latter requires phosphorylation of eNOS at ser-1177 [28-30]. We found eNOS
protein levels and phosphorylation of eNOS at ser-1177 are both decreased in older vs.
young mice under baseline, non-ischemic conditions (Fig. 2a, b); the latter could not solely
be accounted for by decreased eNOS protein levels, as ser-1177 phosphorylation was
diminished even when normalized for eNOS protein levels (Fig. 2b). Thus, aging not only
decreases eNOS protein expression, but also decreases eNOS signaling. Multiple changes
induced by aging probably contribute to the dysfunction of eNOS signaling as well as to the
deleterious alterations in the collateral circulation (Faber et al., unpublished data). For
example, aging increases oxidative stress [7-9] and oxidative stress causes eNOS uncoupling
[9]. When uncoupled, activation of eNOS results in superoxide rather than nitric oxide
production [31], transforming eNOS from a vascular-protective to a vascular-disruptive
enzyme. Although we showed less activation of the eNOS pathway in old mice (decreased
phosphorylation of eNOS; Fig. 2b), the eNOS signaling that exists in these mice may be
causing superoxide production.
Aging-Induced Increased Sensitivity of Endothelial and SMCs CELLS to Apoptosis, an
Effect Attenuated by Molecules Increasing NO Activity
Our recent demonstration that aging leads to collateral “dropout” prompted us to consider
possible mechanisms through which this might occur. The mechanism we examined in this
study was derived from our reasoning that vessel dropout may occur when the cells
comprising these collaterals (endothelial and/or smooth muscle cells) undergo apoptosis.
Our results demonstrated that ECs from old mice, tested in vitro, are more sensitive to
apoptosis induction (Fig. 3a). We postulated that the decrease in eNOS we observed in the
hindlimb of older mice by western blot may partially explain the increased sensitivity to
apoptosis [32]. Interestingly, when ECs were preincu-bated with SNP, an NO donor, the
apoptotic responses were attenuated such that there was no difference between the percent of
old vs. young cells that became apoptotic (Fig. 3b). These findings are supported by the data
of Hoffmann et al. who demonstrated that late passaged ECs (not, however, derived from
old mice) exhibited increased sensitivity to TNF-induced apoptosis compared with early
passaged cells, an effect attenuated by exogenous NO [10].
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We found that SMCs derived from old mice also exhibit increased sensitivity to apoptosis
induction (Fig. 3c), an effect attenuated by pre-incubating the cells with tadalafil, a PDE-5
inhibitor. Tadalafil inhibits PDE-5-induced breakdown of cyclic GMP, which is a critically
important downstream product of NO signaling (Fig. 3d). Thus, these two findings—rescue
of ECs derived from old mice from apoptosis by an NO donor, and rescue of SMCs derived
from old mice by a PDE-5 inhibitor—suggest aging leads to an increased sensitivity of key
vascular wall cells to apoptosis, and that such an effect is mediated, at least in part, by a
dysfunctional eNOS pathway.
An unexpected, novel, and potentially important finding of our study was that PDE-5
mRNA was increased in the SMCs derived from old mice (Fig. 3e). If protein and activity
levels follow mRNA levels, we will have demonstrated a new mechanism contributing to
aging-related dysfunctional eNOS signaling. Such findings would also suggest that PDE-5
inhibitors may improve collateral remodeling in the elderly.
Because of findings we recently reported in a parallel study, we attribute particular
importance to our current observations that aging increases the propensity of cells of the
vascular wall (ECs and SMCs) to apoptosis, and that this effect is rescued by NO-enhancing
drugs. In that independent study, we found in male mice that aging is associated with both
collateral loss and impaired collateral remodeling following acute ligation of the parent
artery. Collateral dropout was determined by two independent experiments. First, we found
that the number of α-SMA-positive vessels crossing the midpoint of the semimembranosis
muscle, the main adductor muscle and a collateral-rich zone, declined with aging. Consistent
with this finding was the observation that hindlimb flow immediately after femoral artery
ligation (which largely reflects flow through pre-existing collaterals) is lower in old mice.
Second, we demonstrated by direct measurement that aging significantly reduces cerebral
collateral number, and third, we found by direct measurement that aging impairs cerebral
collateral remodeling.
These findings, taken together, strongly suggest that an aging-induced increased propensity
to apoptosis of ECs and SMCs lining collateral vessels contributes to collateral rarefaction
and to impaired collateral remodeling, effects mediated, at least in part, by an aging-induced
dysfunction of eNOS/NO signaling. Additional studies will have to be performed, however,
to prove a direct causal link between aging-induced apoptosis and these two critical aging-
related abnormalities of the collateral circulation.
The above findings have important clinical therapeutic implications, as any dropout of
collaterals occurring during aging could impair responsiveness of the target tissue (i.e., the
collaterals) to any collaterogenic therapeutic intervention. Impaired target tissue
responsiveness is further suggested by two additional experiments performed in this
investigation.
Aging-Related Impairment of Endothelial Cell Responsiveness
Endothelial cells are critically important in both angiogenesis and collateral remodeling, as
they must migrate and proliferate in order to contribute to either new vessel development or
existing vessel enlargement. We sought to determine if aging might impair endothelial cell
function. In a Matrigel plug assay, we demonstrated that aging impairs the capacity of ECs
to respond to the potent angiogenic agent bFGF. Thus, cellular infiltration in response to
bFGF-impregnated Matrigel plugs was significantly less in older mice (Fig. 4b) as was the
number of red blood cell-containing vessels (p=0.03) (Fig. 4a, c) and vessels lined by CD31-
positive cells (Fig. 4a).
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Aging-Related Impairment of Bone Marrow-Derived Cells
There is extensive literature [33–35] demonstrating that mobilization of progenitor cells
residing in the BM and their homing to regions of developing collaterals importantly
contribute to collaterogenesis and that aging compromises mobilization/homing [36]. First,
we confirmed that aging impaired mobilization and homing of BM cells existed in our
particular mouse model of aging. We examined gene expression in the BM of CD26
(DPPIV), a key modulator of the CXCR4/SDF-1 binding interaction.
CD26 is expressed on many hematopoietic cells, including stem and progenitor cells [18]. A
membrane-bound extracellular peptidase, CD26 cleaves certain dipeptides from the N
terminus of polypeptide chains. One of its substrates is SDF-1, and when this is cleaved by
CD26 the chemoattractant properties of SDF-1 for CXCR4 are abolished, thereby abolishing
the anchoring properties exerted by the bond created between SDF-1 and CXCR4-
expressing cells. Consequently, such cells are released from their BM niche and into the
circulation.
In our model, we found that old mice have decreased levels of CD26 mRNA in their BM
under baseline conditions (data not shown) and had significantly fewer CD26-positive cells
present 2 h post-hindlimb ischemia induction (Fig. 5), findings compatible with impaired
CD26-mediated mobilization. We also found significantly fewer white blood cells in
peripheral blood 2 h post-ischemia onset, indicating generalized aging-induced impaired cell
mobilization (data not shown) and that when young mice were transplanted with old BM
(see below), homing of BM cells to ischemic tissue was compromised (Fig. 6b).
We next determined whether BMC mobilization and homing, impaired with aging, improve
in old mice receiving BMC transplantation from young donors and, if they are, whether this
improves blood flow recovery of old mice. This would be expected unless collateral
responsiveness was impaired by aging.
We did find increased levels of CD26 mRNA in BM (Fig. 6b), and significantly more BM-
derived cells in the ischemic tissue of mice, whether old or young, when BM was
reconstituted with young BM (Fig. 6b). However, despite the greater homing of cells to
ischemic tissue when transplanting young BM into old mice, blood flow recovery failed to
improve (Fig. 6c, d). These results are compatible with our hypothesis that aging impairs the
responsiveness of collaterals to stimuli that would be expected to enhance collateral
function. This conclusion is supported by the results in a very different model. Thus, Chang
et al., using an ischemic flap model, demonstrated that when young BM is transplanted into
aged hosts perfusion of the flap is identical to that of aged controls [37].
Conclusions
Our results suggest that aging-induced impaired collateral remodeling and collateral dropout
may result in part from an increased sensitivity of ECs and SMCs to apoptosis ensuing from
a dysfunctional NOS/NO signaling pathway. Furthermore, aging impairs mobilization of
bone marrow progenitor cells and their homing to the region of developing collaterals.
While mobilization and homing improve when old mice are transplanted with young BMCs,
the presence of these young cells at the site of collateral development do not lead to
improved flow recovery following femoral artery ligation, suggesting that aging also impairs
the responsiveness of collateral vessels to angiogenic intervention.
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Fig. 1. a Blood flow recovery in a 4-, 10- and 18-month-old C57BL/6J mice, as measured using
LDPI. Flow recovery is impaired in 10 and 18 vs. 4 month-old mice (*p<0.001, by RMANOVA
for the entire curve). b LDPI images from day 21 post-ligation
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Western blotting was carried out in the calf muscle of older mice at baseine (prior to
surgery), and compared with younger mice, and quantified using densitometry. a Western
blots. b The ratio of phosphorylated/total eNOS protein levels was significantly lower in old
vs. young mice (*p=0.015). eNOS/G=eNOS/GAPDH, p-eNOS/G=p-eNOS/GAPDH
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Cells derived from young vs. old mice are more sensitive to an apoptotic stimulus. When
endothelial cells are exposed to TNF-α, the “old” cells are more sensitive to this apoptotic
stimulus, as reflected by a greater increase in caspase levels (a). Exposure of cells to sodium
nitroprusside (SNP), an NO donor, attenuates the TNF-α-induced apoptotic response (b).
SMCs derived from old mice are also more sensitive to an apoptotic stimulus. In this case
the apoptotic stimulus is H2O2(c). Exposure of cells to tadalafil, which inhibits degradation
of cyclic GMP (a critical downstream product of eNOS signaling), the apoptotic response to
H2O2 is attenuated (d). SMCs isolated from old mice have more PDE-5 mRNA expression
that young SMCs (e)
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Representative sections from the Matrigel plug assay. In (a), top left, young, 1 μg/ml bFGF;
lower left, old, 1 μg/ml bFGF. Both are stained with H&E. Middle panels are stained for
CD31, and right panels are negative controls. Angiogenesis was markedly impaired with
aging, as fewer infiltrating cells and RBC containing vessels were present in Matrigel plugs
at each concentration of bFGF (b, c)
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Fig. 5. There were more CD26-positive BM cells in young vs. old mice (p<0.05)
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a Mice reconstituted with BM from young donors had more CD26 mRNA present in BM
(p=0.01) and b a greater number of LacZ-positive cells present in the ischemic tissue at 28
days post-surgery than mice reconstituted with BM from old donors. This was observed for
both young and old recipients (p=0.006 and p=0.01, respectively). c, d BM transplantation
studies showed that young recipients have better flow recovery regardless of the age of the
donor marrow (young recipients, young donors (green)), (young recipients, old donors
(pink)) while old recipients had poor flow recovery regardless of the age of the donor
marrow (old recipient, young donor (red)), (old recipient, old donor (blue)). Specifically, the
age of the donor does not matter (p=0.340), rather it is the age of the recipient (p <0.001).
LDPI images (c) are from day 21 post-ligation
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